Chen, Sijia <br/><br/>
Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.  [electronic resource] 

 -  Journal of autoimmunity  07 2020 
 - 102435 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-9157 
<br/><br/><label>Standard No.: </label>10.1016/j.jaut.2020.102435  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents--pharmacology<br/>Cells, Cultured<br/>Class I Phosphatidylinositol 3-Kinases--antagonists & inhibitors<br/>Female<br/>Fibroblasts--physiology<br/>Humans<br/>Immunity, Innate<br/>Interleukin-17--metabolism<br/>Lymphocytes--immunology<br/>Male<br/>Middle Aged<br/>Osteogenesis<br/>Psoriasis--immunology<br/>Pyridines--pharmacology<br/>Quinolines--pharmacology<br/>Spondylitis, Ankylosing--immunology<br/>Synoviocytes--physiology<br/>Th17 Cells--immunology